| mhGAP intervention Guide–Version 2.0 for mental, neurological and substance user disorders in non-specialized health settings World Health Organization World Health Organization, Geneva, 2016 | 1234* | 2016 |
| Guidelines for the identification and management of substance use and substance use disorders in pregnancy World Health Organization | 626* | 2014 |
| Guidelines for the psychosocially assisted pharmacological treatment of opioid dependence World Health Organization http://www.who.int/substance_abuse/publications/opioid_dependence_guidelines.pdf, 2009 | 542 | 2009 |
| Evidence-based guidelines for mental, neurological, and substance use disorders in low-and middle-income countries: summary of WHO recommendations T Dua, C Barbui, N Clark, A Fleischmann, V Poznyak, M van Ommeren, ... PLoS medicine 8 (11), e1001122, 2011 | 371 | 2011 |
| Community Management of Opioid Overdose World Health Organization | 218 | 2014 |
| Comparative efficacy and acceptability of psychosocial interventions for individuals with cocaine and amphetamine addiction: A systematic review and network meta-analysis F De Crescenzo, M Ciabattini, GL D’Alò, R De Giorgi, C Del Giovane, ... PLoS Medicine 15 (12), e1002715, 2018 | 206 | 2018 |
| Buprenorphine diversion and injection in Melbourne, Australia: an emerging issue? RA Jenkinson, NC Clark, CL Fry, M Dobbin Addiction 100 (2), 197-205, 2005 | 181 | 2005 |
| What data are available on the extent of illicit drug use and dependence globally? Results of four systematic reviews L Degenhardt, C Bucello, B Calabria, P Nelson, A Roberts, W Hall, ... Drug Alcohol Depend 117 (2-3), 85-101, 2011 | 163 | 2011 |
| Challenges in developing evidence-based recommendations using the GRADE approach: the case of mental, neurological, and substance use disorders C Barbui, T Dua, M van Ommeren, MT Yasamy, A Fleischmann, N Clark, ... PLoS Medicine 7 (8), e1000322, 2010 | 143 | 2010 |
| Drug use disorders: impact of a public health rather than a criminal justice approach ND Volkow, V Poznyak, S Saxena, G Gerra, UWHOIIS Network World Psychiatry 16 (2), 213, 2017 | 137 | 2017 |
| COVID-19 and substance use disorders: Recommendations to a comprehensive healthcare response. an international society of addiction medicine practice and policy interest group … A Farhoudian, A Baldacchino, N Clark, G Gerra, H Ekhtiari, G Dom, ... Basic and Clinical Neuroscience 11 (2), 133, 2020 | 135 | 2020 |
| LAAM maintenance vs methadone maintenance for heroin dependence.(Cochrane Review) N Clark, N Lintzeris, A Gijsbers, G Whelan, A Dunlop, A Ritter, W Ling Cochrane Database Syst Rev 2, 2002 | 125* | 2002 |
| Implementing buprenorphine treatment in community settings in Australia: experiences from the Buprenorphine Implementation Trial N Lintzeris, A Ritter, M Panjari, N Clark, J Kutin, G Bammer The American Journal on Addictions 13 (S1), S29-S41, 2004 | 86 | 2004 |
| National clinical guidelines and procedures for the use of buprenorphine in the treatment of opioid dependence N Lintzeris, N Clark, A Winstock, A Dunlop, P Muhleisen, L Gowing, R Ali, ... Canberra: Commonwealth of Australia, 2006 | 81 | 2006 |
| mhGAP intervention guide for mental, neurological and substance use disorders in non-specialized health settings. World Health Organization | 69* | 2010 |
| Adapting harm reduction services during COVID-19: lessons from the supervised injecting facilities in Australia A Roxburgh, M Jauncey, C Day, M Bartlett, S Cogger, P Dietze, S Nielsen, ... Harm reduction journal 18, 1-10, 2021 | 44 | 2021 |
| Severe opiate withdrawal in a heroin user precipitated by a massive buprenorphine dose NC Clark, N Lintzeris, PJ Muhleisen Medical Journal of Australia 176 (4), 166-167, 2002 | 44 | 2002 |
| The role of Cochrane reviews in informing international guidelines: a case study of using the Grading of Recommendations, Assessment, Development and Evaluation system to … M Davoli, L Amato, N Clark, M Farrell, M Hickman, S Hill, N Magrini, ... Addiction 110 (6), 891-898, 2015 | 36 | 2015 |
| WHO guidelines for HIV/STI prevention and care among MSM and transgender people: implications for policy and practice J Cohen, YR Lo, CF Caceres, JD Klausner, ... Sexually transmitted infections 89 (7), 536-538, 2013 | 32 | 2013 |
| A randomized trial comparing levo‐alpha acetylmethadol with methadone maintenance for patients in primary care settings in Australia AJ Ritter, N Lintzeris, N Clark, JJ Kutin, G Bammer, M Panjari Addiction 98 (11), 1605-1613, 2003 | 30 | 2003 |
